Rezolute, Inc.

RZLT · Nasdaq · SIC 2834: Pharmaceutical Preparations
293
SEC Filings

Business Summary

PART I . Rezolute, Inc. (Rezolute, the Company, we or us) is a late-stage rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism (HI). Summary of Clinical Assets Ersodetug Our lead clinical asset, ersodetug, is a potential treatment for hypoglycemia caused by multiple forms of hyperinsulinism. Ersodetug is an intravenously administered human monoclonal antibody that binds to a unique site (allosteric) on the insulin receptor i...

Next Earnings

Q2 FY2026 — expected 2026-09-13

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionRZLTdiscussed_in_filing Cybersecurity
topic_mentionRZLTdiscussed_in_filing Trusted Computing
topic_mentionRZLTdiscussed_in_filing Blockchain & Crypto
topic_mentionRZLTdiscussed_in_filing Capital Expenditure
topic_mentionRZLTdiscussed_in_filing Regulation
topic_mentionRZLTdiscussed_in_filing Healthcare & Bio
topic_mentionRZLTdiscussed_in_filing Sovereign & Government
topic_mentionRZLTdiscussed_in_filing Cybersecurity
topic_mentionRZLTdiscussed_in_filing Trusted Computing
topic_mentionRZLTdiscussed_in_filing Blockchain & Crypto
topic_mentionRZLTdiscussed_in_filing Capital Expenditure
topic_mentionRZLTdiscussed_in_filing Regulation
topic_mentionRZLTdiscussed_in_filing Healthcare & Bio
topic_mentionRZLTdiscussed_in_filing Sovereign & Government
topic_mentionRZLTdiscussed_in_filing Cybersecurity
topic_mentionRZLTdiscussed_in_filing Trusted Computing
topic_mentionRZLTdiscussed_in_filing Blockchain & Crypto
topic_mentionRZLTdiscussed_in_filing Capital Expenditure
topic_mentionRZLTdiscussed_in_filing Regulation
topic_mentionRZLTdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-09-172025-06-300001104659-25-090848EDGAR42K words
2024-09-192024-06-300001558370-24-012901EDGAR—
2023-09-142023-06-300001558370-23-015755EDGAR—
2022-09-152022-06-300001558370-22-014432EDGAR—
2021-09-152021-06-300001104659-21-115980EDGAR—
2020-10-132020-06-300001104659-20-114497EDGAR—
2019-09-102019-06-300001144204-19-043983EDGAR—
2018-10-152018-06-300001144204-18-053849EDGAR—
2017-09-222017-06-300001144204-17-049237EDGAR—
2016-09-282016-06-300001144204-16-125780EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-02-122025-12-310001104659-26-014334EDGAR23K words
2025-11-062025-09-300001104659-25-107781EDGAR—
2025-05-132025-03-310001558370-25-007582EDGAR—
2025-02-122024-12-310001558370-25-000867EDGAR—
2024-11-072024-09-300001558370-24-014893EDGAR—
2024-05-152024-03-310001558370-24-008294EDGAR—
2024-02-132023-12-310001558370-24-001069EDGAR—
2023-11-132023-09-300001558370-23-018839EDGAR—
2023-05-112023-03-310001558370-23-009405EDGAR—
2023-02-102022-12-310001558370-23-001120EDGAR—
2022-11-092022-09-300001558370-22-017176EDGAR—
2022-05-122022-03-310001558370-22-008563EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-240001104659-26-033592EDGAR1K words
2026-02-120001104659-26-014287EDGAR—
2026-01-070001104659-26-001556EDGAR—
2025-11-210001104659-25-115050EDGAR—
2025-11-120001104659-25-109559EDGAR—
2025-11-060001104659-25-107743EDGAR—
2025-10-210001104659-25-101282EDGAR—
2025-09-170001104659-25-090834EDGAR—
2025-09-020001104659-25-085892EDGAR—
2025-08-200001104659-25-080473EDGAR—

293 total filings indexed. 261 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001509261
TickerRZLT
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedNV

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 59a67216a60b590f9a39b9f2fe4c5b17c547548f5fda065d2e8f01b2151534eb
parent: 9eedcf69310d081ce474515ae1085fccade817557713e6847c339ad99f41960c
content hash: 2adf3da7c8de30ff1f024f4fd48707cbc4c717d9bddace076e1e99222b08b818
signed: 2026-04-13T04:47:18.022Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf